About Bryce Riegel
Bryce Riegel is a Technical Specialist on the firm’s Chemistry & Life Sciences team.
Bryce works closely with chemical, biotechnology, and pharmaceutical clients to facilitate application drafting, patent prosecution, and IP portfolio management.
Bryce Riegel earned his Ph.D. from Georgetown University where his research investigated mechanisms of drug resistance in malaria parasites.
- Georgetown University, Ph.D. 2020
- University of Tulsa, B.S. Biochemistry 2014
District of Columbia
Registered to practice before the U.S. Patent and Trademark Office
Publications & Presentations
Altered Drug Transport by Plasmodium falciparum Chloroquine Resistance Transporter Isoforms Harboring Mutations Associated with Piperaquine Resistance.Riegel B, Roepe PD. Biochemistry. 2020 Jul 14;59(27):2484-2493. doi: 10.1021/acs.biochem.0c00247.
An ortholog of Plasmodium falciparum chloroquine resistance transporter (PfCRT) plays a key role in maintaining the integrity of the endolysosomal system in Toxoplasma gondii to facilitate host invasion. Thornton LB, Teehan P, Floyd K, Cochrane C, Bergmann A, Riegel B, Stasic AJ, Di Cristina M, Moreno SNJ, Roepe PD, Dou Z. PLoS Pathog. 2019 Jun 6;15(6):e1007775. doi: 10.1371/journal.ppat.1007775.
Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms. Hassett MR, Riegel BE, Callaghan PS, Roepe PD. Biochemistry. 2017 Oct 17;56(41):5615-5622. doi: 10.1021/acs.biochem.7b00749.
Heterologous Expression, Purification, and Functional Analysis of Plasmodium falciparum Phosphatidylinositol 3′-Kinase. Hassett MR, Sternberg AR, Riegel BE, Thomas CJ, Roepe PD. Biochemistry. 2017 Aug 22;56(33):4335-4345. doi: 10.1021/acs.biochem.7b00416.